Delivery Order SPE2DR25D2104-SPE2DR26F3SDG
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,495.08 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count units) under a firm fixed price contract type. The order, issued on November 10, 2025, with an ultimate completion date of November 12, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $10,036.57 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count units) under a firm fixed-price contract type. The award was made on August 26, 2025, with an ultimate completion date of August 27, 2025, and represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery order from its Conshohocken facility. This...
- The Defense Logistics Agency awarded a delivery order valued at $13,867.55 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count units). This firm fixed-price delivery order, executed on December 4, 2025, with completion targeted for December 5, 2025, represents a competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $3,439.75 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count) under a firm fixed price contract. The award, issued on March 18, 2025, with an ultimate completion date of March 19, 2025, represents a non-competitive delivery order executed through an existing indefinite delivery contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order valued at $2,980.57 to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count packaging) under a firm fixed price contract mechanism. The award, issued on November 10, 2025, with an ultimate completion date of November 12, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count) with a ceiling value of $1,510.60. This non-set-aside, competitively awarded contract reflects a firm fixed price delivery order with an ultimate completion date of September 9, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $14,851.46 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets in a 30-count package. This firm fixed price, competitively awarded contract was issued on June 2, 2025, with an ultimate completion date of June 3, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside procurement, this delivery order represents a routine pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,399.55 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count units) under a firm fixed-price contract. This delivery order, issued on November 25, 2025, with an ultimate completion date of November 26, 2025, represents a non-set-aside competitive award to support federal medical supply needs. The place of performance is the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $13,026.20 to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Rexulti 3 mg tablets (30-count units). This firm fixed-price, non-competitive delivery order is scheduled for completion by June 30, 2025, with performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $12,572.79 to AmerisourceBergen Drug Corp for the supply of Rexulti 3 mg tablets (30-count packages) on September 8, 2025. This competitively awarded, firm fixed-price contract is classified as a non-set-aside procurement and is scheduled for completion by September 9, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3SDGDelivery Order
The Defense Logistics Agency has awarded a delivery order valued at $12,658.75 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count packaging). This is a firm fixed price, non-competitive delivery order with an ultimate completion date of December 23, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. The order will be fulfilled from the company's corporate office location in Conshohocken, PA. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities. The underlying IDC represents DLA's strategic approach to pharmaceutical procurement, positioning AmerisourceBergen as a key vendor for Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.7k | 12/21/25 |